Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds. - Wikidata - awgldk - TriplyDB

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

http://www.wikidata.org/entity/Q35089434

about

Cloning retinoid and peroxisome proliferator-activated nuclear receptors of the Pacific oyster and in silico binding to environmental chemicals.Triphenyltin recognition by primary structures of effector proteins and the protein network of Bacillus thuringiensis during the triphenyltin degradation process Real-time and label-free analysis of binding thermodynamics of carbohydrate-protein interactions on unfixed cancer cell surfaces using a QCM biosensor.Dynamics of nuclear receptor gene expression during Pacific oyster development.Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells Obesogens: an emerging threat to public health.Mass spectrometric analysis of protein-ligand interactions.Comment on "On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens".Transactivation of the human retinoid X receptor by organotins: use of site-directed mutagenesis to identify critical amino acid residues for organotin-induced transactivation.Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells.Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes.

P2860

Q33584820-69CD3921-9238-46DC-A8C5-3C248AAFE409 Q33830138-EDB2E70C-2624-442C-B7DA-045F6C47D1D0 Q36060542-A87CD40D-6F62-4A1B-9C52-2DDFD42578DB Q36146828-80A18238-BF4D-4E7F-969B-5AF0E2BF027A Q36332209-ECBD0F01-AC7A-47A9-88DA-A93351CB1B5F Q36853195-B4D1DF4C-BA0D-4C0D-8364-C20A426EE6EC Q37296199-49786CB3-9F75-4588-9FD5-E2BBF41D0698 Q37580570-1F2F9FAB-9513-4EEF-936A-855441FBE890 Q38873620-787724E7-7593-4AE1-AADB-8EC2095B88F2 Q41203823-F0D04829-2566-4889-AEF9-4220B0868151 Q48137852-62368A03-46F6-4F68-A795-6C5030166004

P2860

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

http://www.wikidata.org/entity/Q35089434

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@ast

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@en

type

label

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@ast

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@en

prefLabel

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@ast

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@en

P1433

Q35089434-66A9F6C6-C899-406A-BC35-9E647B49565E

P1476

Q35089434-A2DF2D4E-CED7-4A18-8FBE-C698F6627E0A

P2093

Q35089434-04142DC0-DCA9-4923-988E-3C902332524E

Q35089434-1F4E608B-5748-4054-A4CA-FC031F58F53D

Q35089434-204B59B6-F714-4033-B989-FBC98D70F87F

Q35089434-3E1181E5-9675-4592-80D3-24DE27333DBB

Q35089434-401A1D88-B8BE-47C3-84CF-17A36CF7A06A

Q35089434-539AACFC-ABA1-47A6-A788-959E27815269

Q35089434-66262FAB-3C3E-4676-908B-505D261986BB

Q35089434-7418FB12-29AD-475B-A518-A07D63346F41

Q35089434-75DD3BA3-ADAB-4647-B9E6-BF2B7B402C73

Q35089434-8E2A8D7C-21C4-421E-8CDB-F783201ADE33

P2860

Q35089434-086B10AB-0969-4447-960F-662B2A038326

Q35089434-15FF405F-AB67-43CF-8EEC-080C7C30DA66

Q35089434-1BC6D170-20E7-4B2E-AAA7-8290E92F13D9

Q35089434-31AD5211-0FB6-4FE3-A732-B4DCF71A8A32

Q35089434-3D2A6E3D-D8D6-416B-8D5B-D8C95F1B9AD5

Q35089434-4B50F661-AE6D-4B0E-B199-6DC22F33C69D

Q35089434-4CB1F157-CED8-4F91-9743-B712FF3B6B62

Q35089434-4F00AC94-39CD-40B9-9920-B962C936DCF1

Q35089434-51800A7D-D8AA-423D-A213-F992E53AE82A

Q35089434-5D874CE3-0B4E-4B95-A74E-D797091DFBDA

P2888

Q35089434-0F80072F-7F44-4ACC-9A3B-3323DC3FE21C

P304

Q35089434-1256BA39-3A8D-40DD-A658-A9CE9AEA8C20

P31

Q35089434-31DE5113-0090-4B7F-B670-C99C559AB3BD

P356

Q35089434-764ADA3F-4F3E-4B26-B35D-8C7B5A0FA510

P407

Q35089434-1D7DF4FF-91D7-449A-B5FE-93915E66C768

P478

Q35089434-83307F04-7075-45B8-95AE-79AF43709A7F

P50

Q35089434-731D9869-1106-415E-BC0D-8E9FCC2DA656

Q35089434-7D6E30AF-3768-4AC5-AC2B-9EBDA413F8E4

P577

Q35089434-0A66E75F-CF85-47CE-A451-56859EED6B55

P5875

Q35089434-D6C95AA8-B925-4C39-AB52-4722BBF1C8AC

P698

Q35089434-DC0D411A-0377-43CE-B999-1958C2D241E1

P932

Q35089434-5ACA7907-5980-439E-869E-CC0E1147EFFD

P356

P1433

Scientific Reports

P1476

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.

@en

P2093

Hisamitsu Nagase

http://www.w3.org/2001/XMLSchema#string

Jun-ichi Nishikawa

http://www.w3.org/2001/XMLSchema#string

Kazuki Kawahara

http://www.w3.org/2001/XMLSchema#string

Kiichi Fukui

http://www.w3.org/2001/XMLSchema#string

Masanori Noda

http://www.w3.org/2001/XMLSchema#string

Shunsuke Fukakusa

http://www.w3.org/2001/XMLSchema#string

Shusaku Harada

http://www.w3.org/2001/XMLSchema#string

Tadayasu Ohkubo

http://www.w3.org/2001/XMLSchema#string

Takahiro Maruno

http://www.w3.org/2001/XMLSchema#string

Takuya Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Partial agonists activate PPARgamma using a helix 12 independent mechanism

Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids

Activation of RXR–PPAR heterodimers by organotin environmental endocrine disruptors

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Protein complexes gain momentum.

Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor.

Aromatic rings in chemical and biological recognition: energetics and structures.

Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals.

P2888

P304

8520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP08520

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Susumu Uchiyama

P577

2015-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272511507

http://www.w3.org/2001/XMLSchema#string

P698

25687586

http://www.w3.org/2001/XMLSchema#string

P932

4330522

http://www.w3.org/2001/XMLSchema#string